Government: Page 69
-
AMA calls out shrinking payer competition amid rising antitrust interest in Washington
The study by the physician group is the latest salvo in a messaging war between provider and payer lobbies as they work to shift the blame for rapidly rising medical costs.
By Rebecca Pifer Parduhn • Sept. 29, 2021 -
Alex Wong via Getty Images
CMS defends proposal to nix MCIT pathway, but medtechs hold out hope
If the bid to repeal the breakthrough payment rule is finalized, the agency's CMO committed to an alternative pathway that evaluates devices for Medicare patients potentially via clinical trials, outcome registries and real-world data.
By Greg Slabodkin • Sept. 29, 2021 -
Explore the Trendline➔
Getty Images
TrendlineSurprise Billing
Federal legislation banning surprise bills has hit a barrage of roadblocks, complicating efforts to protect consumers from unexpected out-of-network charges.
By Healthcare Dive staff -
Sarah Silbiger via Getty Images
Top FDA official takes over vaccine office as agency weighs COVID-19 shots for children
Difficult vaccine decisions lie ahead. The agency could soon determine how to handle boosters for recipients of Moderna and Johnson & Johnson's shots.
By Ben Fidler • Sept. 29, 2021 -
Free insurance under COBRA for Americans without job-based coverage ends Thursday
Experts say there was huge demand for the six-month subsidy, with one estimate finding more than 16 million people lost their employer-sponsored health insurance during the pandemic.
By Rebecca Pifer Parduhn • Sept. 29, 2021 -
Lance Cheung. (2018). "20180927-RD-LSC-0093" [Photograph]. Retrieved from Flickr.
OpinionBroadband investments can improve health, as long as insurers don't roll back telehealth coverage
Jason Resendez of Consumers for Quality Care argues it's time for insurers, policymakers and health systems to embrace telehealth as an integral part of the future of healthcare.
By Jason Resendez • Sept. 27, 2021 -
Mark Wilson via Getty Images
6 drug companies could face steep fines for violating 340B law
The ongoing refusal of Eli Lilly, AstraZeneca, Novartis, Novo Nordisk, Sanofi and United Therapeutics to offer discounts to safety-net providers through community pharmacy partnerships has been referred to OIG for enforcement.
By Rebecca Pifer Parduhn • Sept. 24, 2021 -
Sarah Silbiger via Getty Images
FDA green lights booster dose of Pfizer vaccine for older, more vulnerable Americans
The authorization is more narrow than envisioned by the Biden administration last month, but still makes potentially millions of Americans eligible for a third Pfizer shot.
By Shoshana Dubnow • Sept. 23, 2021 -
Kevin C. Cox via Getty Images
CDC recommends Pfizer booster shots for many, overruling advisers on broad use
Though an agency panel voted against advising a third Pfizer vaccine dose for younger people in high-risk jobs like nursing or teaching, it was overriden by CDC Director Rochelle Walensky.
By Shoshana Dubnow , Ned Pagliarulo • Updated Sept. 24, 2021 -
Mario Tama via Getty Images
State Medicaid officials face daunting fall season amid low vaccination rates, record enrollment
Telehealth and behavioral health service needs are also a challenge as the COVID-19 pandemic drags on and the Biden administration encourages more people to get on the rolls.
By Hailey Mensik • Sept. 23, 2021 -
OIG flags potential $5B overpaid to Medicare Advantage plans
The watchdog calls out 20 private insurers, which it does not name, and urges CMS to conduct greater oversight.
By Samantha Liss • Sept. 22, 2021 -
Jon Cherry via Getty Images
Second dose of J&J's coronavirus vaccine increases protection, company says
Long-awaited results from a Phase 3 study run by J&J could support use of a booster dose, although the drugmaker has not officially applied for FDA clearance yet.
By Shoshana Dubnow • Sept. 21, 2021 -
Antonio Masiello via Getty Images
Pfizer says coronavirus vaccine is safe, spurs immune response in children
The results position Pfizer and BioNTech to seek clearance in children as young as 5 years old. But the companies haven't yet shared data on a rare heart inflammation associated with their shot that's a concern for regulators.
By Jonathan Gardner • Sept. 21, 2021 -
Jens Schlueter via Getty Images
FDA advisers support booster dose of Pfizer vaccine in older or high-risk adults
In a back-and-forth meeting Friday, the committee opposed clearing a third shot widely for use in people older than 16, but agreed the benefits outweighed the risks for adults over 65 or those at risk of severe COVID-19.
By Shoshana Dubnow , Ned Pagliarulo • Updated Sept. 17, 2021 -
Permission granted by University of Maryland School of Medicine
New data from Israel, Pfizer show potent effect from third coronavirus shot
The much-anticipated data arrived two days before an important FDA advisory meeting to discuss authorization of a booster dose for Pfizer's coronavirus vaccine.
By Jonathan Gardner • Sept. 16, 2021 -
Carol Highsmith. (2005). "Apex Bldg." [Photo]. Retrieved from Wikimedia Commons.
FTC warns app makers fall under breach notification rule
The agency noted that a breach must be reported regardless of whether it was the result of malicious action. Any unauthorized access, including sharing information without consent, would trigger the rule.
By Shannon Muchmore • Sept. 16, 2021 -
Getty Images
FDA staff tight-lipped on booster shot views ahead of consequential meeting
In a briefing document released Wednesday, agency reviewers did not make a strong case either for or against the broad authorization of boosters for the general public.
By Shoshana Dubnow • Sept. 16, 2021 -
Providers balk at MIPS value program, Medicare rate in physician pay rule comments
While providers strongly support the telehealth coverage increases in the proposed rule, they asked the agency to go further by putting the services that are now going to be covered through the end of 2023 on the permanent list.
By Shannon Muchmore • Sept. 15, 2021 -
In rare move, DOJ intervenes in MA fraud case against data mining company
Defendants Independent Health, an MA payer, and its now defunct medical analytics subsidiary DxID denied all allegations of wrongdoing and said they planned to defend themselves "vigorously" in court.
By Rebecca Pifer Parduhn • Sept. 15, 2021 -
Alex Wong via Getty Images
CMS moves to scrap Medicare coverage of breakthrough devices due to clinical evidence concerns
AdvaMed said the repeal of the Medicare Coverage of Innovative Technology rule is the wrong decision for patients. Analysts noted the reimbursement pathway could be resurrected in Cures 2.0 legislation.
By Nick Paul Taylor • Sept. 14, 2021 -
Alex Wong via Getty Images
Biden pushes forward on Medicare price negotiation
But opposition from the drug industry and Republicans could make the Democrats' signature proposal an uphill battle.
By Jonathan Gardner • Sept. 13, 2021 -
Mario Tama via Getty Images
Departing FDA officials, WHO leaders argue against broad rollout of COVID-19 booster shots
Marion Gruber and Philip Krause, two top FDA vaccine reviewers who are unexpectedly departing this fall, joined senior WHO officials in saying booster vaccine doses are not yet widely needed.
By Ned Pagliarulo • Sept. 13, 2021 -
HHS to release $25.5B in COVID-19 relief funding for providers
Some providers have been anxiously waiting on additional disbursements from the provider relief fund, especially for the period of the pandemic that saw the highest hospitalization rates.
By Samantha Liss • Sept. 13, 2021 -
Mario Tama via Getty Images
Insurers to disclose relationships with brokers, agents in new CMS proposed rule
Other proposals would require air ambulances to disclose additional data to HHS and outline how CMS can enforce surprise billing protections if states fail to act.
By Rebecca Pifer Parduhn • Sept. 13, 2021 -
Retrieved from Shutterstock.
Sponsored by Consensus Cloud Solutions4 ways ADT event notifications improve payer performance
Our all-in-one real-time health event notification solution allows payers to work alongside providers to ensure that their members are on a path to better health outcomes that reduces waste and frustration.
By Bevey Miner, Health IT Strategy/CMO for Consensus • Sept. 13, 2021 -
Jens Schlueter via Getty Images
Biden, industry groups mandate COVID-19 vaccines for most healthcare workers
CMS and the Centers for Disease Control and Prevention are requiring that all provider facilities that participate in the Medicare and Medicaid programs vaccinate their workers, according to a Thursday release.
By Ron Shinkman • Sept. 10, 2021
Previous
